BTBD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.90847337933064E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.85280013553779E-10 |
Normal-vs-Stage2 |
3.999700E-03 |
Normal-vs-Stage3 |
2.8421709430404E-14 |
Normal-vs-Stage4 |
5.86499737664781E-11 |
Stage1-vs-Stage2 |
4.770400E-01 |
Stage1-vs-Stage3 |
2.570000E-04 |
Stage1-vs-Stage4 |
1.730270E-02 |
Stage2-vs-Stage3 |
1.507940E-02 |
Stage2-vs-Stage4 |
5.783700E-02 |
Stage3-vs-Stage4 |
4.951200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63424829224823E-13 |
Normal-vs-AfricanAmerican |
2.185599999871E-07 |
Normal-vs-Asian |
7.429800E-02 |
Caucasian-vs-AfricanAmerican |
5.154400E-01 |
Caucasian-vs-Asian |
3.559400E-01 |
AfricanAmerican-vs-Asian |
4.568600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.30582219984399E-12 |
Normal-vs-Female |
5.56980017663022E-11 |
Male-vs-Female |
8.622800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.26040000003602E-06 |
Normal-vs-Age(41-60Yrs) |
3.3447999925329E-10 |
Normal-vs-Age(61-80Yrs) |
1.75037762062402E-12 |
Normal-vs-Age(81-100Yrs) |
2.49820000242096E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.246200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.737200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.723800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.114000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.648300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.288600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.675300E-03 |
Normal-vs-Grade 2 |
4.92090002079948E-09 |
Normal-vs-Grade 3 |
1.62647673107585E-12 |
Normal-vs-Grade 4 |
2.29471996959774E-12 |
Grade 1-vs-Grade 2 |
6.742400E-01 |
Grade 1-vs-Grade 3 |
1.742550E-01 |
Grade 1-vs-Grade 4 |
7.474300E-02 |
Grade 2-vs-Grade 3 |
1.266180E-02 |
Grade 2-vs-Grade 4 |
6.522000E-03 |
Grade 3-vs-Grade 4 |
1.982630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.5802995557741E-10 |
Normal-vs-ccB subtype |
8.62580007421343E-10 |
ccA subtype-vs-ccB subtype |
7.901000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.02420302741757E-11 |
Normal-vs-N1 |
2.254000E-02 |
N0-vs-N1 |
9.909000E-01 |
|
|